Dr Reddy's Laboratories (FRA:RDDA) Short Interest


FRA:RDDA Dr Reddy's Laboratories Ltd FRA:RDDA
91 GF Score
Price €13.20
GF Value €13.78
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Dr Reddy's Laboratories Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:RDDA vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr Reddy's Laboratories Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's Short Interest distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's Short Interest falls into.


FRA:RDDA
91GF Score
Dr Reddy's Laboratories Ltd FRA:RDDA
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Dr Reddy's Laboratories (FRA:RDDA) Overvalued in 2026?

Based on GuruFocus' analysis, Dr Reddy's Laboratories stock appears to be undervalued. The current stock price of €13.20 is trading 4.2% below its estimated GF Value™ of €13.78. GuruFocus considers Dr Reddy's Laboratories to be Fairly Valued.

Key valuation signals for FRA:RDDA:

  • Short Interest:
  • GF Value™: €13.78 vs. price of €13.20 (4.2% below fair value)
  • GF Score™: 91/100 with 5 warning signs

No single metric tells the full story. See the FRA:RDDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dr Reddy's Laboratories Business Description

Address 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
91GF Score

Get the complete analysis for FRA:RDDA

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.20
Price
€13.78
GF Value